[对两例遗传性纤维蛋白发育不良症的分子致病机制研究]
Min Wang1, Tian-Ping Chen1, Ao-Shuang Jiang1
1Department of Hematology & Oncology, Anhui Provincial Children's Hospital, Hefei 230022, Anhui Province, China.
Zhongguo shi yan xue ye xue za zhi
|February 28, 2025
概括
分析了两家遗传性纤维蛋白酶血症的家庭,揭示了FGA和FGG基因中的致病性异构基因突变. 这些遗传变化会影响纤维蛋白质的结构和稳定性,导致出血障碍.
科学领域:
- 血液学 血液学 血液学
- 分子遗传学 分子遗传学
- 生物化学 生化学
背景情况:
- 遗传性纤维蛋白质血症是一种罕见的出血障碍,由影响纤维蛋白质功能的遗传突变引起.
- 了解纤维蛋白缺血的分子基础对于诊断和潜在的治疗策略至关重要.
研究的目的:
- 在两个不同的家族中研究遗传性纤维蛋白发育不良症的基因和分子机制.
- 识别纤维素基因 (FGA,FGB,FGG) 的特定突变并评估其致病影响.
主要方法:
- 在受影响的个人和家庭成员中评估了凝血参数.
- 用PCR放大和测序来识别FGA,FGB和FGG基因中的突变.
- 生物信息学工具 (SIFT,PolyPhen2,等等) 的使用. 和蛋白质建模 (PyMOL,Clustal X) 用于预测已识别的突变的功能后果.
主要成果:
- 家庭1试验对象表现出延长的血栓激素时间和降低的纤维素水平,具有异构的FGA基因突变 (c.80T>C,Phe27Ser).
- 家庭2的试验样本显示纤维素水平降低,FGG基因突变异构 (c.1007T>A,Met336Lys).
- 生物信息学和结构分析预测这两种突变都是有害的,导致蛋白质结构改变,稳定性降低,并影响高度保存的氨基酸残留物.
结论:
- 在FGA (c.80T>C) 和FGG (c.1007T>A) 中发现的异构突变是致病性的.
- 这些突变通过破坏纤维素原的结构和功能,导致遗传性纤维素原体缺血症.
更多相关视频
07:09Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
11.4K
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
11.1K
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
Extrinsic and Intrinsic Pathways of Hemostasis
4.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.7K
Pedigree Analysis
83.7K
Overview
83.7K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
X-linked Traits
53.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
